Fundz

Shennon Biotechnologies raises $12M in financing for its precision immunotherapy pipeline and appoints Cyril Konto, M.D., as Chief Executive Officer.

PRIVATESep 14, 2026

Amount Raised

$12 Million

Round Type

Venture

San FranciscoBiotechnology

Description

Shennon Biotechnologies has successfully raised $12 million in financing. The funds will be utilized to support the development of its precision immunotherapy pipeline. Additionally, Cyril Konto, M.D., has been appointed as the new Chief Executive Officer. This move is expected to bolster the company's leadership as it progresses in the biotechnology field.

Quick answer

Shennon Biotechnologies raised $12 Million in a funding round, dated September 14, 2026. Shennon Biotechnologies is based in San Francisco, California, United States.

How much did Shennon Biotechnologies raise?
Shennon Biotechnologies raised $12 Million in a funding round on September 14, 2026.
What does Shennon Biotechnologies do?
ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy.
Where is Shennon Biotechnologies based and how big is it?
Shennon Biotechnologies is based in San Francisco, California, United States. Fundz records about 17 employees.
Who are the decision-makers at Shennon Biotechnologies?
Fundz holds 1 contact at Shennon Biotechnologies, including the Founder/CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Shennon Biotechnologies that raised within 45 days of this round, from Fundz verified event records.

  • VUSE XR raised $1.3M (Pre-Seed) on October 29, 2026.
  • Opentrons Labworks raised $40M (Series E) on October 29, 2026.
  • Sonocare Lab raised an undisclosed amount (Seed) on October 29, 2026.
  • Quantum Universal raised $109M on October 29, 2026.
  • StimCardio raised $30M (Series A) on October 29, 2026.
  • Happy Health raised $75M on October 29, 2026.

Who to call at Shennon Biotechnologies, and when

A new round usually means Shennon Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Shennon Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Shennon Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Shennon Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Shennon Biotechnologies

Location

953 INDIANA STREET

San Francisco, California, United States

About

ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Shennon Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLi, Founder/CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Shennon Biotechnologies's next move

See what Strategic adds

Shennon Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.